FLGC
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Flora Growth holds a Neutral rating with a composite score of 42.8, reflecting a lack of compelling dynamics to significantly adjust current positions. The strongest pillar contributions come from regulatory factors, presenting a balanced but unremarkable attitude towards compliance within its operational jurisdiction. Regulatory pillar support stands at 50.0, bolstered by a stable framework and an absence of enforcement events which provides some confidence, but not sufficient to elevate conviction beyond a 2 out of 5.
The company's revenue growth is notable, outperforming peers with significant year-over-year gains. Despite this, fundamental concerns arise from their financial structure. A stretched financial condition combined with weak gross and operating margins signals the firm’s current struggles to convert revenue into profit effectively. The market capitalization categorizes Flora Growth in the smaller tier, which when coupled with a high cash burn ratio, reflects challenges in sustainability. Without recent regulatory filings within the past 180 days, financial transparency remains opaque, leaving investors blind to current fiscal movements.
Future developments hinge largely upon regulatory developments. With the regulatory pillar as the strongest contributor, continuous monitoring of shifts in Latin American regulatory stances is essential. Changes in jurisdictional posture could materially impact strategic positions and potentially enhance compliance efficacy. The anticipated catalyst lies within regulatory evolutions, which remain the most significant signal to track as the business navigates its constrained financial landscape.
- SEC CIK
- 0001790169
- Website
- Company website
- Market cap
- $5.8M
- Enterprise value
- $71.6M
- Price to book
- 0.33
- Price to sales
- 0.37
- EV / EBITDA
- -1.00
- Revenue (TTM)
- $57.6M
- Gross profit (TTM)
- $12.1M
- EBITDA
- $-13.7M
- Operating margin
- -33.5%
- Profit margin
- -27.7%
- Rev growth YoY
- 34.7%
- Return on equity
- -45.3%
- Return on assets
- -17.5%
- EPS (TTM)
- $-41.09
- EPS est. current year
- $-23.01
- Wall St. target price
- $30.00
- Shares outstanding
- 0.7M
- Insider ownership
- 16.6%
- Institutional ownership
- 2.1%
- Beta
- 1.87
- Full-time employees
- 64
- GICS sector
- Financial Services
- GICS industry
- Asset Management
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for FLGC (FLGC)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for FLGC (FLGC), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for FLGC are maintained by Cannabis Investor News and refreshed throughout the trading day.